Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Raymond

Showing results (211-220 of 345) with videos related to

Pageof 35
Sort By:
Pharmaceutical Research|January 12, 2023
Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer ChemopreventionNahal Habibi, Caroline Bissonnette, Ping Pei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 25, 2012
Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative studyGus Theodos, Chad Raymond, Matthew C Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patientsE Izbicka, R Lawrence, E Raymond, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Anti-Cancer Drugs|October 19, 2000
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude miceC Louvet, A M Coudray, C Tournigand, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Oncoimmunology|December 10, 2020
PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinomaD Evrard, M Hourseau, A Couvelard, et al.
Polymers for Advanced Technologies|July 24, 2018
Tungsten-loaded SMP foam nanocomposites with inherent radiopacity and tunable thermo-mechanical propertiesSayyeda M Hasan, Garrett Harmon, Fang Zhou, et al.
The Journal of Arthroplasty|April 10, 2022
Racial Differences in Manipulation Under Anesthesia Rates Following Total Knee ArthroplastyJoseph P Barbera, Hayley E Raymond, Nicole Zubizarreta, et al.
Pageof 35

Showing results (211-220 of 345) with videos related to

Sort By:
Pageof 35
Pharmaceutical Research|January 12, 2023
Mucopenetrating Janus Nanoparticles For Field-Coverage Oral Cancer ChemopreventionNahal Habibi, Caroline Bissonnette, Ping Pei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 25, 2012
Arteriotomy closure device safety after percutaneous coronary intervention in the direct thrombin inhibitor era: a comparative studyGus Theodos, Chad Raymond, Matthew C Becker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patientsE Izbicka, R Lawrence, E Raymond, et al.
British Journal of Cancer|December 24, 2010
Single agent and combination studies of pralatrexate and molecular correlates of sensitivityM Serova, I Bieche, M-P Sablin, et al.
Anti-Cancer Drugs|October 19, 2000
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude miceC Louvet, A M Coudray, C Tournigand, et al.
Bulletin Du Cancer|February 15, 2001
[Zd 1839 "Iressa"]J B Meric, S Faivre, C Monnerat, et al.
Oncoimmunology|December 10, 2020
PD-L1 expression in the microenvironment and the response to checkpoint inhibitors in head and neck squamous cell carcinomaD Evrard, M Hourseau, A Couvelard, et al.
Polymers for Advanced Technologies|July 24, 2018
Tungsten-loaded SMP foam nanocomposites with inherent radiopacity and tunable thermo-mechanical propertiesSayyeda M Hasan, Garrett Harmon, Fang Zhou, et al.
The Journal of Arthroplasty|April 10, 2022
Racial Differences in Manipulation Under Anesthesia Rates Following Total Knee ArthroplastyJoseph P Barbera, Hayley E Raymond, Nicole Zubizarreta, et al.
Pageof 35